Skip to main content
BCRX logo

BCRX · Biocryst Pharmaceuticals Inc · Holdings

Track BCRX — free
$8.21 -0.19 (-2.26%)
Market Cap
$2.15B
Shares
255.54M
Volume · Oct 8 5.1M Avg daily vol (3M) 4.16M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 319
Total Value: $2,638,238,995
Total Shares: 263,874,789
Showing 1–100 of 332 holdings by value · page 1 of 4

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 320 13F filers
Top Holder
9.1%
Sep 2023 → Jun 2026 · range 9.0% – 13.0%
of institutional value
Top 5
30.8%
Sep 2023 → Jun 2026 · range 30.7% – 43.1%
of institutional value
Top 10
49.9%
Sep 2023 → Jun 2026 · range 45.2% – 58.9%
of institutional value
HHI
328
Sep 2023 → Jun 2026 · range 326 – 526
Broadly held
Showing 100 of 332
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 882796 CUSIP 09058V103 13F (30d) 10 filings 9 filers Visit website Investor relations